Education
About Us
Working with TipRanks
Follow Us
Alphatec Holdings (DE:L1Z1)
FRANKFURT:L1Z1
L1Z1 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€4.36 - €13.90
Previous CloseN/A
Volume150.00
Average Volume (3M)50.00
Market Cap
$1.84B
Enterprise Value€2.12B
Total Cash (Recent Filing)$157.06M
Total Debt (Recent Filing)$586.63M
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Oct 30, 2025EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding147,983,780
10 Day Avg. Volume0
30 Day Avg. Volume50
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)-92.61
Price to Sales (P/S)2.15
P/FCF Ratio-9.52
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue3.10
Enterprise Value/Gross Profit4.51
Enterprise Value/Ebitda-31.08
Forecast
1Y Price Target
$15.77Price Target Upside27.50% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAlphatec reported total revenues of $186M for the quarter, higher than consensus estimate of $179M.
Market GrowthValence positions ATEC to accelerate its spine market share gains.
Product InnovationATEC will close the only gap in its enabling technology portfolio by commercializing the latest generation Valence robotic navigation system.
Bears Say
International Revenue ImpactInternational revenues are not expected to make a material impact to the topline in 2025.
Profitability ConcernsATEC generated $5M of FCF and management's 3Q25 guide suggests they could reach breakeven on a TTM basis.
Alphatec Holdings News
L1Z1 FAQ
What was Alphatec Holdings’s price range in the past 12 months?
Alphatec Holdings lowest stock price was €4.36 and its highest was €13.89 in the past 12 months.
What is Alphatec Holdings’s market cap?
Alphatec Holdings’s market cap is $1.84B.
When is Alphatec Holdings’s upcoming earnings report date?
Alphatec Holdings’s upcoming earnings report date is Oct 30, 2025 which is in 42 days.
How were Alphatec Holdings’s earnings last quarter?
Alphatec Holdings released its earnings results on Jul 31, 2025. The company reported €0.017 earnings per share for the quarter, beating the consensus estimate of -€0.038 by €0.055.
Is Alphatec Holdings overvalued?
According to Wall Street analysts Alphatec Holdings’s price is currently Undervalued.
Does Alphatec Holdings pay dividends?
Alphatec Holdings does not currently pay dividends.
What is Alphatec Holdings’s EPS estimate?
Alphatec Holdings’s EPS estimate is -0.03.
How many shares outstanding does Alphatec Holdings have?
Alphatec Holdings has 147,983,780 shares outstanding.
What happened to Alphatec Holdings’s price movement after its last earnings report?
Alphatec Holdings reported an EPS of €0.017 in its last earnings report, beating expectations of -€0.038. Following the earnings report the stock price went up 9.212%.
Which hedge fund is a major shareholder of Alphatec Holdings?
Currently, no hedge funds are holding shares in DE:L1Z1
Alphatec Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.77 (27.50% Upside)
$15.77 (27.50% Upside)
Blogger Sentiment
Bullish
DE:L1Z1 Sentiment 66%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
147.05%
12-Months-Change
Fundamentals
Return on Equity
-376.89%
Trailing 12-Months
Asset Growth
2.82%
Trailing 12-Months
Company Description
Alphatec Holdings
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement. It also provides Invictus Modular Fixation Systems designed to increase adaptability with the power of screw modularity; OsseoScrew system to restore the integrity of the spinal column; Arsenal spinal fixation system, a comprehensive thoracolumbar fixation platform to fix a range of degenerative to deformity pathologies and surgical procedures; Aspida Anterior Lumbar Plating System, a fixation system for anterior lumbar interbody fusion; AMP Anti-Migration Plate; OCT Spinal Fixation System; trestle luxe anterior cervical plate system; and Insignia Anterior Cervical Plate System. In addition, the company offers IdentiTi Porous Ti, Transcend Lateral, and Battalion Posterior Interbody Implants; and biologics consisting of Cervical Structural Allograft Spacers, 3D ProFuse Demineralized Bone Scaffold, Neocore Osteoconductive Matrix, Alphagraft Demineralized and Cellular Bone Matrix, and Amnioshield Amniotic Tissue Barrier, as well as EOS imaging products. It sells its products through a network of independent distributors and direct sales representatives in the United States. The company was founded in 1990 and is headquartered in Carlsbad, California.
L1Z1 Company Deck
L1Z1 Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong quarter with record financial performance, significant revenue growth, and strategic market positioning. While there are some challenges such as flat gross margins and anticipated tariff impacts, the overall outlook remains positive with increased guidance and strong cash flow.View all DE:L1Z1 earnings summariesL1Z1 Stock 12 Month Forecast
Average Price Target
€15.77
▲(27.50% Upside)
Technical Analysis
Options Prices
Currently, No data available
---